In our study, we found that the expression of VEGFA was stably downregulated in SPRY4‐IT1‐silenced glioma cells, while VEGFA was strongly upregulated in SPRY4‐IT1‐overexpressed cells. This evidence concerns the gene SPRY4 and central nervous system cancer.